Seizures in an Alzheimer's disease patient as a complication of colonoscopy premedication with meperidine.
We describe the first reported case of generalized tonic-clonic seizures induced by meperidine premedication for a colonoscopy procedure in a 63-year-old woman with Alzheimer's disease. The active metabolite of meperidine, normeperidine, is postulated to be the precipitating cause of the seizures, although a cholinesterase inhibitor and an N-methyl-D: -aspartate receptor antagonist, both routinely used for treatment of Alzheimer's disease, may have contributed by reducing the seizure threshold. The neuronal changes which occur in Alzheimer's disease can themselves also predispose to seizures. We recommend avoidance of meperidine for all flexible endoscopic procedures on patients with Alzheimer's disease and in any patient with a condition that predisposes to seizures, and suggest the use of alternative opioids.
Nagler
Jerry
J
Weill Medical College of Cornell University, New York, NY 10021, USA. Jnagler407@aol.com
Hammarth
Patricia M
PM
Poppers
David M
DM
D000759:Adjuvants, Anesthesia / Q000009:adverse effects* / Q000627:therapeutic use; D000544:Alzheimer Disease / Q000150:complications*; D046730:Colitis, Lymphocytic / Q000150:complications / Q000175:diagnosis*; D003113:Colonoscopy / Q000009:adverse effects / Q000379:methods*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008614:Meperidine / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D011292:Premedication / Q000009:adverse effects* / Q000379:methods; D012640:Seizures / Q000139:chemically induced*
D000759:Adjuvants, Anesthesia; D008614:Meperidine